Govt concern prompts audit of science skills shortage
26 April, 2005 by Graeme O'NeillThe federal government has released a discussion paper on Australia's growing shortage of skilled professionals in science, engineering and technology (SET).
Q1 results: Serono, Schering, Affymetrix, Chugai, Shire
26 April, 2005 by Staff WritersShares in Swiss biotechnology company Serono have tumbled after the firm unexpectedly booked US$725 million to cover legal costs relating to an investigation into US sales of its Serostim AIDS drug.
Universities combine forces to form new meditech
26 April, 2005 by Graeme O'NeillIn a rare example of cross-pollination, the University of Sydney and the University of Western Sydney have pooled the IP from three advanced research projects on inflammation and cancer, and spun out a new biomedical company, Medical Therapies.
Optiscan claims good results from Pentax partnership
21 April, 2005 by Graeme O'NeillThe 25,000 doctors attending the world's largest gastroenterology meeting in Chicago next month will be briefed about a revolution in the detection and diagnosis of gastrointestinal diseases, engineered by Melbourne's Optiscan (ASX:OIL) and its giant Japanese partner Pentax.
In brief: Select Vaccines, Psiron, Visiomed
21 April, 2005 by Graeme O'NeillSelect Vaccines' (ASX:SLT) hepatitis E diagnostics kits have gained CE Mark approval for sale in the European Union. The company will sell the kits from June this year through its licencee, Genelabs
Q4 profits: Wyeth; Biocon
21 April, 2005 by Staff WritersWyeth's first-quarter earnings have risen 44 percent as sales of its vaccine against childhood infections more than doubled and sales of arthritis treatment Enbrel and other prescription drugs rose.
Beattie announces $473m funding boost
19 April, 2005 by Graeme O'NeillQueensland's Beattie Government has announced AUD$473 million in new funding for the second phase of its Smart State Strategy.
Invest in basic science to reap rewards: expert
14 April, 2005 by Staff WritersMark Crowell -- a leading US technology-transfer expert -- has a message for Australian universities wanting to make money out of research: it is vital that the public sector continue funding good, basic science to drive the knowledge economy.
Vic govt announces $57m in infrastructure grants
14 April, 2005 by Renate KrelleA tissue engineering centre, a tumour tissue banking facility and a biopharmaceutical formulation facility are three of 17 projects that will share a total of $57 million in major infrastructure grants, announced today by the Victorian government.
Australians publishing more, but not patenting: report
13 April, 2005 by Renate KrelleAlthough government and higher education R&D expenditure are on the up, and Australia generated almost 50 per cent more scientific and technical articles in 2003 than in 1999, the number of US patents granted to Australia has fallen, a government report has revealed.
Database access helps protect privacy: Stanley
13 April, 2005 by Susan WilliamsonWestern Australia's well-established record-linked healthcare database had been an important innovation for research, but had also helped to better awareness of privacy issues, according to Prof Fiona Stanley, director of the Telethon Institute for Child Health Research in Perth.
In brief: AustCancer; Life Therapeutics; Amrad; Genesis Research; Avastra
13 April, 2005 by Staff WritersAustralian Cancer Technology (ASX:ACU) has announced a 1:3 non-renounceable entitlements issue, aiming to raise $5.7 million at $0.13 per share. Shares in the company were trading at $0.17 at time of writing.
Sydney firm Apollo aims for sweet lift-off
08 April, 2005 by Graeme O'NeillDo you want sugars with that? Sydney protein specialist Apollo is planning an IPO next month to raise funds to develop its extensive portfolio of glycosylated proteins as research agents and therapeutics.
Making strange or making sense - art and the life sciences
07 April, 2005 by Oron Catts and Ionat ZurrOron Catts and Ionat Zurr talk about the future with Bioart.
In brief: Benitec, XRT, Phylogica, Norwood Abbey
06 April, 2005 by Staff WritersRNAi specialist Benitec (ASX:BLT) has lodged a prospectus with ASIC to raise up to AUD$9.7 million in a rights issue, underwritten by Bell Potter. Capital raised will go towards clinical development and expansion of Benitec's California operations, it said.
